PCK

3.23%

3.0¢ painchek ltd

Ann: Quarterly Update and Appendix 4C, page-45

First 45 Last

Share
Profile

Follow
zmans

14,696 Posts.

1505

07/02/18

11:44

Post #: 30883975
Share
Originally posted by GCInvestor ↑

got a reply

Hello xxxxxx

Ian Hobson forwarded me your inquiry. I have been travelling this week so delayed in responding.

You are broadly right with your assumption, but I need to clarify a couple of points.

DSA are a government funded agency comprising 200 specialist consultants who provide a specific support service for people living with dementia in any environment. DSA are also part of Hammondcare one of the leading aged care and home care service provider. Our current agreement is with DSA only but we hope to extend it to the broader Hammondcare group in the future.

DSA have their own bespoke database/CRM system to capture all their consultants visits and document the diagnosis, assessments and treatments as is standard practise within aged care and healthcare in general. We are now working with DSA to incorporate PainChek™ into their database/CRM to also automatically store the pain score results. This will automate the documentation, allow for aggregation of data and hopefully lead to a better understanding of pain scores and related treatment benefits.

Part of our overall strategy is to incorporate PainChek™ into all providers of backend clinical systems to provide the same benefits to all customers. There are 3-4 major clinical system providers in Australia who supply 80% + of the Australian aged care market and we are in advanced talks with one and opened talks with two others. This was also mentioned in the earlier section of the recent quarterly update.

So in summary our goal is to incorporate PainChek™ into all clinical systems so the results will be automatically available throughout their aged care or hospital facilities. And as you pointed out, this can provide additional cost benefit and automation/documentation benefits in addition to the clinical outcome benefits.

Hope this helps clarify the point.

Kind regards,
Philip
Philip Daffas
CEO
PainChek Ltd

Expand

Great work GC, wonder how many of our Aged Care partners will be signed up this Q, as it does sound like one is very close. I reckon Hammond Care will be first up.
PCK Price at posting: 5.4¢ Sentiment: None Disclosure: Held
11 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BUX

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

There are more pages in this discussion • 1 more message in this thread...

First 45 Last

Add PCK (ASX) to my watchlist

(20min delay)
Last 3.0¢		Change -0.001(3.23%)		Mkt cap ! $49.11M

Open	High	Low	Value	Volume
3.0¢	3.0¢	3.0¢	$12.08K	402.6K

Buyers (Bids)

No.	Vol.	Price($)
8	305189	3.0¢

Sellers (Offers)

Price($)	Vol.	No.
3.1¢	99999	1

View Market Depth

No.	Vol.	Price($)
8	305189	0.030
5	6607448	0.029
1	350000	0.028
3	488344	0.027
4	1600000	0.026

Price($)	Vol.	No.
0.031	99999	1
0.032	102605	2
0.033	126161	2
0.034	79638	2
0.035	125000	1

Last trade - 16.10pm 04/10/2024 (20 minute delay)

PCK (ASX) Chart

Ann: Quarterly Update and Appendix 4C, page-45

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Quarterly Update and Appendix 4C, page-45

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News